J&J'S $1 BIL ACQUISITION OF KODAK CLINICAL DIAGNOSTICS DIVISION
This article was originally published in The Gray Sheet
Executive Summary
J&J'S $1 BIL ACQUISITION OF KODAK CLINICAL DIAGNOSTICS DIVISION gives the company three product lines in the clinical chemistry and immunodiagnostic areas to complement its existing diagnostic business. The companies announced an agreement Sept. 6 under which Johnson & Johnson would pay $1.008 bil. for all the technology, production equipment, products, and roughly 450 patents of Kodak's Clinical Diagnostics business. Kodak's 2,800 employees worldwide, including a U.S. sales force of about 200, will become employees of J&J.